News | SPECT Imaging | February 15, 2024

Please be aware, this recall is a correction, not a product removal.

The FDA recalls the Philips BrightView XCT

Image courtesy of Philips


February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling its BrightView, BrightView X, and BrightView XCT, as the detector may unexpectedly fall due to a component failure. Update as of 12:59 pm 2/15/24 from the FDA: Please be aware, this recall is a correction, not a product removal.

Use of the affected device may cause a person to experience neck injury, contusion, traumatic brain injury/concussion, death, crush injury, fracture, laceration, muscle or ligament sprain/strain, as well as an interruption to the BrightView system operation. If detector is positioned above the large opening of the device (the center of the gantry), there may be an interruption to normal system operation.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Please be aware, this recall is a correction, not a product removal.

Recalled Product

  • Product Names: BrightView, BrightView X, BrightView XCT
  • Product Codes: See Recall Database Entry
  • Model Numbers:
    • BrightView: 882480; 453560279781, 453560279791, 453560279811, 453560279801, 2170-3000A, 2170-3001A, 2170-3002A, 2170-3003A
    • BrightView X: 882478; 453560824741, 453560829261
    • BrightView XCT: 882482; 453560462131, 453560749161
  • Manufacturing Dates: September 2007 to June 2013
  • Distribution Dates: November 29, 2007 to June 5, 2013
  • Devices Recalled in the U.S.: 553
  • Date Initiated by Firm: December 15, 2023

Device Use

The Philips Brightview system is a Single Photon Emission Computed Tomography (SPECT) machine used to take images showing biological activity in the human body, for medical personnel to review. The BrightView XCT model combines SPECT and Computed Tomography (CT) imaging.

Reason for Recall

Philips is recalling their BrightView, BrightView X, and BrightView XCT, as the detector may unexpectedly fall due to a component failure.

A falling detector may cause a person to experience neck injury, contusion, traumatic brain injury/concussion, death, crush injury, fracture, laceration, muscle or ligament sprain/strain, as well as an interruption to the BrightView system operation. If detector is positioned above the large opening of the device (center of the gantry), there may be an interruption to normal system operation.

There has been one reported incident from use of this device, and no reports of injuries or deaths.

Who May be Affected

  • People who receive scans using a Philips BrightView, BrightView X, BrightView XCT.
  • Health care providers who use BrightView Camera Systems to obtain detailed pictures or measurements of the human body.
  • Field service engineers who service a Philips BrightView, BrightView X, BrightView XCT.

What to Do

On December 16, 2023, Philips sent all affected customers an Urgent Medical Device Correction letter.

The letter requested all affected users to not position a patient's lower limbs directly under the detector, below the center of the gantry. If the detector is above the center of the gantry and the detector support component fails, the detector will not be able to move to complete the imaging.

The letter also described two scenarios:

  • Scenario 1: Detector positioned below the center of the gantry: If the patient’s lower limb(s) is directly below the lower detector and the support component fails, the detector may descend downward in an uncontrolled manner and contact the patient.
  • Scenario 2: Detector above the center of the gantry: If the support component fails, the detector will remain in place, and will not move as intended for clinical imaging, resulting in an interruption to normal system operation. A rescan or re-injection of radiopharmaceutical to the patient may be required.

Philips will contact customers to schedule a time for a Philips Field Service Engineer (FSE) to visit the customer site and correct the system if necessary.

Contact Information

Customers in the U.S. with questions about this recall should contact the Customer Care Solutions Center at 1-800-722-9377.

Additional Resources

How do I report a problem?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program using an online form, regular mail, or FAX.


Related Content

News | Computed Tomography (CT)

April 17, 2025 — NANO-X IMAGING LTD has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Time April 18, 2025
arrow
News | Breast Imaging

April 15, 2025 — CureMetrix, a provider of AI-driven medical imaging solutions, has announced that its AI-based cmAngio ...

Time April 17, 2025
arrow
News | Radiation Dose Management

April 7, 2025 — DOSIsoft, a provider of patient-specific imaging and dosimetry software solutions, recently announced ...

Time April 08, 2025
arrow
News | Prostate Cancer

March 28, 2025 — Novartis has announced that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu ...

Time March 31, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | Computed Tomography (CT)

March 10, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for its Naeotom Alpha class of ...

Time March 11, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Prenuvo has announced FDA clearance for its AI-powered Prenuvo Body Composition report, marking a significant milestone ...

Time February 13, 2025
arrow
News | Prostate Cancer

Feb. 10, 2025 —Ibex Medical Analytics recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) ...

Time February 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Artificial Intelligence

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 ...

Time February 04, 2025
arrow
Subscribe Now